- The key vendors in the global biologic therapeutics market 2015-2019 are Amgen, F. Hoffmann-La Roche, Novo Nordisk, and Sanofi.
London, 19 October 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global biologic therapeutics market 2015-2019. Emergence of targeted and combination therapies is one of the key trends being witnessed in this market. Targeted therapies cause fewer side effects than conventional non-targeted therapies. They generally exploit those surface markers or properties of diseased/infected cells that are absent or present in a lesser amount in normal cells. The global biologic therapeutics market is expected to grow at a CAGR of 8.26% during the forecast period of 2014-2019.
“Biologic therapeutic vendors are shifting their focus to developing economies as they offer large population groups as customers and clinical trial subjects. Emerging economies are increasingly becoming aware of the importance of drug designations, such as orphan drug designations, and are thereby working on the development of regulatory protocols required to award these designations,” says Faisal Ghaus, Vice President of Technavio Research.
“The rising GDPs and increasing awareness among the middle-class population have increased the acceptance of biologic therapeutics in the BRIC countries. These countries are also working on providing incentives such as reimbursements to pharmaceutical manufacturers to encourage research focused on biologic therapeutics.”
To define the market conditions in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
If you are interested in more information on this topic and our upcoming research on the Global Biologic Therapeutics Market 2015-2019, please send an e-mail to media@TechNavio.com
Follow us on Twitter @Technavio
Like us on Facebook
Follow us LinkedIn
Connect with us on Google+
